PatientsLikeMe Stock
Personalized health network
Sign up today and learn more about PatientsLikeMe Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About PatientsLikeMe Stock
PatientsLikeMe, the world’s largest personalized health network, helps people find new options for treatments, connect with others, and take action to improve their outcomes. The company has worked with every major pharmaceutical company and a range of government organizations to bring the patient voice to research, development and public policy. With more than 500,000 members, PatientsLikeMe is a trusted source for real-world disease information and a clinically robust resource that has published more than 100 research studies.
Investors
Collaborative Seed & Growth Partners
Funding History
| February 2007 | $5.0M |
|---|---|
| August 2010 | $8.0M |
| August 2012 | $2.0M |
| June 2013 | $12.0M |
| January 2017 | $100M |
Management
VP of Innovation
Paul Wicks
Co Founder & Chairman
James Heywood
Director, Data Science
Timothy Vaughan
Executive Vice President, Research and Development (R&D)
Jonathan White
Co-Founder, President
Ben Heywood
Vice President of Advocacy Policy & Patient Safety
Sally Okun
Executive Vice President, Business Solutions and Partnerships
Monique Levy
Executive Vice President of Human Resources
George Parker
EVP Marketing & Patient Advocacy
Michael Evers
Program Director, Client Services
Rishi Bhalerao
Press
Business Wire (press release) - Aug, 2 2017
PatientsLikeMe Names Greg Ploussios Senior Vice President and General CounselBusiness Wire (press release) - Jun, 14 2017
PatientsLikeMe Poll Reveals Must-Haves for Health Care LawBusiness Wire (press release) - Apr, 10 2017
PatientsLikeMe and Shire Pharmaceuticals Collaborate to Study Rare Genetic DiseasesXconomy - Jan, 6 2017
PatientsLikeMe Nabs $100M, Works to Advance Personalized MedicineEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
